MultiPlan Corporation (MPLN)
NYSE: MPLN · Real-Time Price · USD
6.80
-1.17 (-14.61%)
Dec 3, 2024, 12:24 PM EST - Market open
MultiPlan Market Cap
MultiPlan has a market cap or net worth of $109.96 million as of December 3, 2024. Its market cap has decreased by -86.88% in one year.
Market Cap
109.96M
Enterprise Value
4.60B
1-Year Change
-86.88%
Ranking
Category
Stock Price
$6.80
Market Cap Chart
Since April 3, 2020, MultiPlan's market cap has decreased from $243.00M to $109.96M, a decrease of -54.75%. That is a compound annual growth rate of -15.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 128.88M | -86.22% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 132.48M |
| Renovaro | 130.15M |
| Lineage Cell Therapeutics | 130.05M |
| Skye Bioscience | 129.85M |
| TriSalus Life Sciences | 129.29M |
| Cardiol Therapeutics | 127.01M |
| Immunic | 126.11M |
| Telomir Pharmaceuticals | 125.84M |